WORTHING MUSICAL THEATRE COMPANY

Registered charity 1205488 · accounts filings on the Charity Commission register

TO EDUCATE THE PUBLIC IN THE DRAMATIC AND OPERATIC ARTS AND TO FURTHER THE DEVELOPMENT OF PUBLIC APPRECIATION AND TASTE IN THE SAID ARTS. THE COMPANY PRESENTS DRAMATIC PERFORMANCES IN WORTHING

Causes: General Charitable Purposes · Education/training · Arts/culture/heritage/science · website · Get email alerts

Latest income
£106k
Latest spending
£86k
Registered
2023
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that unrestricted reserves stood at £70,110, which is above the stated policy target of £21,300 to £42,600. The charity reported a net income surplus of £20,627 for the year, having spent £85,528 on charitable activities against total income of £106,155.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: three to six months unrestricted expenditure (held: £70k)
Worthing Musical Theatre Companys aims to accumulate reserves equal to three to six months unrestricted expenditure. Running costs for the charity are approximately £7,100 per month, therefore our reserves target is between £21,300 to £42,600.
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: West Sussex

Income and spending

Financial year endIncomeSpending
31/05/2025£106k£86k
31/05/2024£44k£40k

Common questions

Is WORTHING MUSICAL THEATRE COMPANY financially healthy?

Per its FY2025 accounts: The accounts state that unrestricted reserves stood at £70,110, which is above the stated policy target of £21,300 to £42,600. The charity reported a net income surplus of £20,627 for the year, having spent £85,528 on charitable activities against total income of £106,155. Its FY2025 accounts were independently examined.